Categories
COVID Links from other news sources. Medicine Reprints from others. Science

Discovering the disinformation playbook An excerpt from ‘The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic’, by Dr. Pierre Kory

Discovering the disinformation playbook  An excerpt from ‘The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic’, by Dr. Pierre Kory

Having fought in the “War on Ivermectin” now for almost two and half years, I know most of the military plays. But when I first set foot on the bat­tlefield, I was blissfully unaware of the rules of engagement. Hell, I didn’t even know I was fighting in a war.

One thing was crystal clear to me: Something illicit was happening around ivermectin, and Big Pharma’s fingerprints were all over the crime scene. But in the beginning, I truly believed that the pandemic would be over in a matter of months—just as soon as our review paper was published. The world would know that there was an incredibly effective agent to pre­vent and treat Covid-19; deaths would stop, and life would resume.

It physically pains me to write that last sentence.

I credit my combat training to two people, both of whom appeared in my life around the same time. The first was a man who writes under the pen name Justus Hope, MD, author of Ivermectin for the World. I had come across his book as well as multiple articles published in a California newspaper called The Desert Review in my researchso I knew who he was when he reached out. We had several in-depth conversations during which he explained his long-standing interest in Big Pharma’s war on repurposed drugs. That interest was triggered by a close friend with brain cancer which led him to the discovery that there were multiple effective repurposed drugs to treat cancer that had long been suppressed by Big Pharma. Early in the pandemic, he published a book called Surviving Cancer, Covid-19, and Disease: The Repurposed Drug Revolution. I was beginning to understand that this was an old, old war.

My second mind-altering mentor during this period was a complete stranger named Bill Grant, PhD, a physicist and the founder and president of the Sunlight, Nutrition, and Health Research Center in San Francisco. Bill is also one of the world’s foremost experts on the science behind vitamin D, with more than 300 peer-reviewed papers to his name. Out of the blue, Bill reached out to me in March of 2021 with a simple, two-line email:

Dear Dr. Kory,
What they are doing to ivermectin they have been doing to Vitamin D for decades. Bill

The note was followed by a link to an article by a group of scientists detailing precisely how disinformation is used to sway public opinion. Intrigued, I clicked the link.

The article described various disinformation tactics by equating them to American football plays. By the time I got to the end of that article, a switch inside me had flipped. I instantly knew that it was the key to understanding a world that I no longer recognized.

The article went on to detail five primary disinformation “plays” or tac­tics used by companies or industries when science emerges that is inconvenient to their interests: the fake, the fix, the blitz, the diversion, and the screen. As I read, I could think of dozens of examples for every single one of those maneuvers that had occurred around ivermectin since my senate testimony had gone viral.

The mother of all Macy’s 4th of July fireworks celebrations was going off in my brain; one realization exploding after another, each one brighter and more astonishing than the last.

Holy crap. The FLCCC was in the middle of a disinformation war with the pharmaceutical industry.

From that day on, that conceptual framework was the only thing that could make sense of what had happened and what was yet to happen in my attempts to highlight one of the safest and most effective treatments in any disease in history.

Although each play was widely represented in the events surrounding the Covid response, “the fake” was by far the most prominent—and the most damaging. In regard to repurposed drugs specifically, it involves con­ducting trials “designed to fail,” selectively publishing negative results while censoring positive results, and planting negative ghost-written editorials in legitimate journals. The article emphasized that these tactics can gravely undermine public health and safety.

You don’t say.

“The fake” formed the foundation of a campaign that would result in one of the most significant humanitarian catastrophes in history, causing millions of deaths around the world.

To be clear, ivermectin wasn’t the first casualty of World War Covid. The same tactics had been used against hydroxychloroquine (HCQ) in 2020 and had they not, HCQ would have been deployed at the onset of the pandemic and saved even more lives. The closest and best description of that war I’ve discovered was featured in Robert F. Kennedy’s The Real Anthony Fauci (Skyhorse Publishing, 2021)a brilliant, expertly researched, and undeniably incriminating takedown of “America’s Doctor.”

“HHS’s early studies supported hydroxychloroquine’s efficacy against coronavirus since 2005, and by March 2020, doctors from New York to Asia were using it against Covid with extraordinary effect,” Kennedy wrote. By autumn, more than 200 studies supported treatment with hydroxychloro­quine. “From the outset, hydroxychloroquine and other therapeutics posed an existential threat to Dr. Fauci and Bill Gates’ $48 billion Covid vaccine project, and particularly to their vanity drug remdesivir, in which Gates has a large stake. Under federal law, new vaccines and medicines cannot qual­ify for Emergency Use Authorization (EUA) if any existing FDA-approved drug proves effective against the same malady.”

In other words, if HCQ or ivermectin had been recognized as a viable treatment, the massive cash cow that was the global Covid-19 vaccine cam­paign would have been slaughtered on the spot.

Keep in mind that HCQ and ivermectin not only threatened the vac­cine campaign, but also the massive and exploding competitive market for other pricey Big Pharma products like Veklury (commonly known by its generic name, remdesivir), Paxlovid, molnupiravir, and monoclonal anti­bodies. Never in history had two generic, repurposed medicines threatened a marketplace of such a colossal size.

The answer to that pesky little conundrum?

Disinformation.

Over and over, each devious play has been strategically deployed to further the interests of the establishment to the unbridled disservice of mankind.


You can find ‘The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic’ at a bookstore near you.

Categories
Biden Pandemic COVID Drugs Life Science Stupid things people say or do.

White House to invest $5 billion in next-generation COVID vaccines. Here’s why we [don’t] need new ones.

Story by Karen Weintraub, USA TODAY

Bracketed comments by Phoenix

The Biden Administration Monday announced a $5 billion program to accelerate the development of next-generation COVID-19 vaccines and treatments.

[Of course, the elephant in the room is: “Why? We already have effective treatments, ones that don’t kill people.” Oh, wait: they’re cheap, and Big Pharma can’t make more Billion$ from them. Carry on…..]

Like Operation Warp Speed, which developed and distributed vaccines in the early days of the pandemic, Project NextGen will cut across government agencies and involve public-private collaborations, a senior Biden official told USA TODAY.

Current vaccines, developed rapidly in the heat of the emergency, are “really good, but they’re not great,” said Michael Osterholm, an epidemiologist who worked with the administration to develop the new program. “There is a substantial amount of work (to be done) to take these good vaccines and hopefully achieve better vaccines.”

Project NextGen has three primary goals, which Osterholm and colleagues laid out in a “roadmap” issued in February: Develop a nasal vaccine that will hopefully prevent infection as well as severe disease; develop longer-lasting vaccines; and create “broader” vaccines that protect against all variants and several different coronaviruses

[ Why do they need a “new” nasal vax when two already exist? Oh, wait. Same answer.]

It will also include funding to develop more durable monoclonal antibodies resistant to new variants, according to the administration. Antibodies were highly effective treatments earlier in the pandemic but have not been able to keep up with the virus as it evolved and are no longer available.

The Biden administration Monday announced a $5 billion program to accelerate the development of next-generation COVID-19 vaccines and treatments.

Like Operation Warp Speed, which developed and distributed vaccines in the early days of the pandemic, Project NextGen will cut across government agencies and involve public-private collaborations, a senior Biden official told USA TODAY.

Current vaccines, developed rapidly in the heat of the emergency, are “really good, but they’re not great,” said Michael Osterholm, an epidemiologist who worked with the administration to develop the new program. “There is a substantial amount of work (to be done) to take these good vaccines and hopefully achieve better vaccines.”

Project NextGen has three primary goals, which Osterholm and colleagues laid out in a “roadmap” issued in February: Develop a nasal vaccine that will hopefully prevent infection as well as severe disease; develop longer-lasting vaccines; and create “broader” vaccines that protect against all variants and several different coronaviruses

It will also include funding to develop more durable monoclonal antibodies resistant to new variants, according to the administration. Antibodies were highly effective treatments earlier in the pandemic but have not been able to keep up with the virus as it evolved and are no longer available.

The administration said the initial allocation of $5 billion for Project NextGen would be financed through money saved from contracts costing less than originally estimated. The investment was first reported Monday by the Washington Post.

Dr. Gregory Poland, director of the Mayo Clinic’s Vaccine Research Group who was also involved in the earlier roadmap, said he and others have been advising the White House since last summer to launch something like Project NextGen.

The funding is a start, he said, “but much more will be needed to accomplish all three goals,” he said. “The need though is urgent and now – something government generally doesn’t do well, hence the key will be prioritization and implementation.”

The Biden administration Monday announced a $5 billion program to accelerate the development of next-generation COVID-19 vaccines and treatments.

Like Operation Warp Speed, which developed and distributed vaccines in the early days of the pandemic, Project NextGen will cut across government agencies and involve public-private collaborations, a senior Biden official told USA TODAY.

Current vaccines, developed rapidly in the heat of the emergency, are “really good, but they’re not great,” said Michael Osterholm, an epidemiologist who worked with the administration to develop the new program. “There is a substantial amount of work (to be done) to take these good vaccines and hopefully achieve better vaccines.”

Project NextGen has three primary goals, which Osterholm and colleagues laid out in a “roadmap” issued in February: Develop a nasal vaccine that will hopefully prevent infection as well as severe disease; develop longer-lasting vaccines; and create “broader” vaccines that protect against all variants and several different coronaviruses

It will also include funding to develop more durable monoclonal antibodies resistant to new variants, according to the administration. Antibodies were highly effective treatments earlier in the pandemic but have not been able to keep up with the virus as it evolved and are no longer available.

The administration said the initial allocation of $5 billion for Project NextGen will be financed through money saved from contracts costing less than originally estimated. The investment was first reported Monday by the Washington Post.

Dr. Gregory Poland, director of the Mayo Clinic’s Vaccine Research Group who was also involved in the earlier roadmap, said he and others have been advising the White House since last summer to launch something like Project NextGen.

The funding is a start he said, “but much more will be needed to accomplish all three goals,” he said. “The need though is urgent and now – something government generally doesn’t do well, hence the key will be prioritization and implementation.”

Why do we need new coronavirus vaccines?

When the current vaccines were developed, speed was a priority along with safety and effectiveness. They were 95% effective at preventing all disease when first released in late 2020. But their effectiveness against mild disease, in particular, wanes over just a handful of months.

Protection may also not be as good as the virus continues to evolve. The current bivalent booster is aimed at both the original virus and the BA.5 variant.

But SARS-CoV-2, the virus that causes COVID, is the third new coronavirus to pop up in the last two decades, following Middle-Eastern Respiratory Syndrome (MERS) and Severe Acute Respiratory (SARS). If and when a fourth turns up, it would be great to already have a vaccine that could protect against” it,’ said Osterholm, who directs the Center for Infectious Disease Research and Policy at the University of Minnesota.

[ “…when a fourth turns up, it would be great TO ALREADY HAVE a vaccine that could protect against it…”  Hmm, Bill Gates & friends have already told us there’s another pandemic coming, is there something they know that we don’t?]

A nasal vaccine is the third item on the wish list. The idea is that by delivering a vaccine directly to the area where the virus enters the body, scientists could set up a barrier of protection to prevent even mild infections and transmission from one person to the next.

[But didn’t they tell us initially that surface contact would spread it? DISINFECT EVERYTHING! And what about people who breathe more through their mouths — like people with allergies such as Hay Fever?]

“I think an initiative like this is much needed and should have been put in place much sooner,” said John Moore, an immunologist at Weill Cornell Medical College in New York.

What happens next?

Reaching these goals will likely be more difficult than it sounds, Moore said. 

“Anyone familiar with vaccine development knows that translation into a practical product is a much harder and more expensive process” than simply creating a basic vaccine, he said. “A lot of designs that look good in the early stages fizzle out because they cannot be manufactured efficiently under the conditions required for human trials.”

[And when did they have time for human testing under Warp Speed?]

Dr. Paul Offit, a pediatrician who directs the Vaccine Education Center at Children’s Hospital of Philadelphia, is skeptical that any of these goals are realistic.

Researchers have been trying for more than 40 years to develop vaccines against multiple strains of flu and against HIV, the virus that causes AIDS. Both have proven elusive, he said, because the viruses mutate so much, as does SARS-CoV-2.

Meanwhile, nasal vaccines are still being tested in clinical trials, so it’s not yet clear how effective they’ll be against COVID. A nasal vaccine for the flu doesn’t provide any more protection than a shot, Offit said, and it’s most effective in young children who have never been exposed to the flu virus before. At this point, nearly every American has already been exposed to the virus that causes COVID.

Moore agrees that developing a nasal vaccine should be a high priority, but “it’s seriously naive to believe that it will be easy to make one.”

Offit worries that the emphasis on making COVID vaccines better will undermine public trust in the ones we already have. He said the current vaccines have been “amazing,” but that vaccines can only do so much.

What did Operation Warp Speed do?

Under the Trump administration, Operation Warp Speed spent about $30 billion beginning in March 2020 to develop, manufacture and distribute COVID-19 vaccines.

The federal government essentially placed bets on six different drug companies hoping at least a few of them would prove successful. Each received over $1 billion (although Pfizer/BioNTech developed its vaccine without government support) with a promise of a guaranteed market if they succeeded. 

Moderna and Pfizer/BioNTech both developed, tested, passed regulatory hurdles and produced millions of doses of their mRNA vaccines in under a year. Previously, the fastest vaccine had taken four years to bring to market.

Johnson and Johnson also developed a vaccine based on a different technology. While effective, the vaccine led to a rare side effect and is no longer widely available in the United States.

Novavax pursued a third type of vaccine technology and has also won emergency regulatory approval, though it is not widely available.

►The other two efforts, one by Sanofi and another by AstraZeneca, fell behind early and were not advanced beyond preliminary testing.

[It’s obvious I’m skeptical of the claims here. If the previous record for developing a vaccine was FOUR YEARS, how did they manage to develop –AND TEST– them so quickly (less than a third of that time)? Why weren’t these vaccines pulled after the deadly side effects became apparent? It only took a ‘mere’ 50 deaths to yank the swine flu vaccine; how many THOUSANDS have died/been seriously affected by the clot shots?]